Thyroid hormones in the rat amygdala as common targets for antidepressant drugs, mood stabilizers, and sleep deprivation

Biological Psychiatry

Volumn 54, Issue 10, 2003, Pages 1049-1059

  Pinna, Graziano ^a   Broedel, Oliver ^a   Eravci, Murat ^a   Stoltenburg Didinger, Gisela ^a   Plueckhan, Hanna ^a   Fuxius, Sandra ^a   Meinhold, Harald ^a   Baumgartner, Andreas ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Dept of Radiol/Nuclear Medicine ^*  (Germany)

Author keywords

Amygdala; Antidepressants; Mitochondria; Myelin; Rat brain; Triiodothyronine

Indexed keywords

ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CHOLESTEROL; DESIPRAMINE; LIOTHYRONINE; LITHIUM CARBONATE; MITOCHONDRIAL ENZYME; PAROXETINE; SUCCINATE DEHYDROGENASE; THYROID HORMONE; TIANEPTINE; VENLAFAXINE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN MICROSOME; BRAIN SYNAPTOSOME; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; HORMONE DETERMINATION; IMMUNOGOLD LABELING; LIOTHYRONINE BLOOD LEVEL; LIPID COMPOSITION; MALE; MYELINATED NERVE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RAT; SLEEP DEPRIVATION; THYROID HORMONE BLOOD LEVEL;

EID: 0242559022     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(03)00414-1     Document Type: Article

References (56)

1. Anderson G.W., Mariash C.N., Oppenheimer J.H. Molecular actions of thyroid hormone. Braverman L.E., Utiger R.D. Werner & Ingbar's The Thyroid. 8th ed:2000;174-195 Lippincott, New York.
2. Aronson R., Offman H.J., Joffe R.T., Naylor C.D. Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis. Arch Gen Psychiatry. 53:1996;842-848.
3. Aubry J.M., Pozolli G., Vale W.W. Chronic treatment with the antidepressant amitriptyline decreases CRF-R1 receptor mRNA levels in the rat amygdala. Neurosci Lett. 266:1999;197-200.
4. Bauer M., Dopfmer S. Lithium augmentation in treatment-resistant depression Meta-analysis of placebo-controlled studies . J Clin Psychopharmacol. 19:1999;427-434.
5. Baumann P., Gaillard J.M., Jonzier-Perey M., Gerber C., Bouras C. Evaluation of the levels of free and total amitriptyline and metabolites in the plasma and brain of the rat after long-term administration of doses used in receptor studies. Psychopharmacology. 94:1984;489-495.
6. Baumgartner A. Thyroxine and the treatment of affective disorder An overview of the results of basic and clinical research . Int J Neuropsychopharmacol. 3:2000;149-165.
7. Baxter M.G., Murray E.A. The amygdala and reward. Nat Rev Neurosci. 3:2002;563-573.
8. Bowley M.P., Drevets W.C., Öngür D., Price J.L. Low glial numbers in the amygdala in major depressive disorder. Biol Psychiatry. 52:2002;404-412.
9. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254.
10. Chin L.S., Ferreira A., Kosik K.S., Greengard P. Impairment of axonal development and of synaptogenesis in hippocampal neurons of synapsin I-deficient mice. Proc Natl Acad Sci U S A. 92:1995;9230-9234.
11. Cole D.P., Thase M.E., Mallinger A.G., Soares J.C., Luther J.F., Kupfer D.J., Frank E. Slower treatment response in bipolar depression predicted by lower pre-treatment thyroid function. Am J Psychiatry. 159:2002;116-121.
12. Danscher G. Histochemical demonstration of heavy metals. A revised version of the sulphide silver method suitable for both light and electronmicroscopy. Histochemistry. 71:1981;1-16.
13. Dodd R.R., Hardy J.A., Oakley A.E., Edwardson J.A., Perry E.K., Delaunoy J.P. A rapid method for preparing synaptosomes Comparison, with alternative procedures . Brain Res. 226:1981;107-118.
14. Dratman M.B., Crutchfield F.L., Axelrod J., Colburn R.W., Thoa N. Localization of triiodothyronine in nerve ending fractions of rat brain. Proc Natl Acad Sci U S A. 73:1976;941-944.
15. Drevets W.E., Videen T.O., Price J.L., Preskorn S.H., Carmichael S.T., Raichle M.E. A functional anatomic study of unipolar depression. J Neurosci. 12:1992;3628-3641.
16. Drevets W.C. Neuroimaging studies of mood disorders. Biol Psychiatry. 43:2000;813-829.
17. Duman R.S. Synaptic plasticity and mood disorders. Mol Psychiatry. 7:2002;S29-S34.
18. Frye M.A., Denicoff K.D., Bryan A.L., Smith-Jackson E.E., Ali S.O., Luckenbaugh D., et al. Association between lower serum free T4 and greater mood instability and depression in lithium-maintained bipolar patients. Am J Psychiatry. 156:1999;1909-1914.
19. Ganser A.L., Kerner A.L., Brown B.J., Davisson M.T., Kirschner D.A. A survey of neurological mutant mice. I. Lipid composition of myelinated tissue in known myelin mutants. Dev Neurosci. 10:1988;99-122.
20. Gimpl G., Burger K., Fahrenholz F. Cholesterol as modulator of receptor function. Biochemistry. 36:1997;10959-10974.
21. Glowinski I., Iversen L.L. Regional studies of catecholamine metabolism in the rat brain, I. The disposition of (3H) dopamine and (3H) dopa in various regions of the brain. J Neurochem. 13:1966;655-669.
22. Goglia F., Moreno M., Lanni A. Action of thyroid hormones at the cellular level. FEBS Lett. 452:1999;115-120.
23. Gregoraszczuk E.L., Pieklo R. Thyroid hormone action in porcine luteal cells. Effect of triiodothyronine on mitochondrial cytochrome P450-SCC activity. J Physiol Pharmacol. 49:1998;467-475.
24. Joffe R.T., Segal Z., Singer W. Change in thyroid hormone levels following response to cognitive therapy for major depression. Am J Psychiatry. 153:1996;411-413.
25. Johnson A.M. An overview of the animal pharmacology of paroxetine. Acta Psychiatr Scand. 80:(suppl 350):1989;14-20.
26. Johnson M.K., Whittaker V.P. Lactate dehydrogenase as a cytoplasmatic marker in brain. Biochemistry. 88:1962;404-409.
27. Jurevics H., Morell P. Cholesterol for synthesis of myelin is made locally, not imported to the brain. J Neurochem. 64:1995;895-901.
28. Kurihara T., Takahashi Y. Potentiometric and colorimetric methods for the assay of 2′.3′-cyclic nucleotide 3′-phosphohydrolase. J Neurochem. 20:1973;719-727.
29. Lambert P.D., McGirr K.M., Ely T.D., Kilts C.D., Kuhar M.J. Chronic lithium treatment decreases neuronal activity in the nucleus accumbens and cingulate cortex of the rat. Neuropsychopharmacology. 21:1999;229-237.
30. Ledeen R.W. Enzymes and receptors of myelin. Martenson R.E. Myelin Biology and Chemistry. 1992;531-570 CRC Press, Boca Raton, FL.
31. LeDoux J.E. Emotion and the amygdala. Aggleton J.P. The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction. 1992;339-351 Wiley Liss, New York.
32. scc in rat brain . Science. 237:1987;1212-1215.
33. Lovtrup-Rein H., McEwen B.S. Isolation and fractionation of rat brain nuclei. J Cell Biol. 30:1966;405-415.
34. Manji H.K., Drevets W.C., Charney D.S. The cellular neurobiology of depression. Nat Med. 7:2001;541-547.
35. Manji H.K., Chen G. PKC, MAP kinase and the bcl-2 family pf proteins as long-term targets for mood stabilizers. Mol Psychiatry. 7:2002;S46-S56.
36. Mashio Y., Inada M., Tanaka K., Ishii H., Naito K., Nishikawa M., et al. Synaptosomal T3 binding sites in rat brain Their localisation on synaptic membrane and regional distribution . Acta Endocrinol. 104:1983;134-138.
37. Meinhold H. Radioimmunoassay of iodothyronines. Hennemann G. Thyroid Hormone Metabolism. 1986;133-186 Marcel Dekker, New York.
38. Morell P., Quarles R.H., Norton W.T. Myelin formation, structure, and biochemistry. Siegel G.J. Basic Neurochemistry: Molecular, Cellular, and Medical Aspects. 5th ed:1994;117-143 Raven Press, New York.
39. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron. 34:2002;13-25.
40. Nestler E.J., Gould E., Manji H., Bucan M., Duman R.S., Gershenfeld H.K., et al. Preclinical models Status of basic research in depression . Biol Psychiatry. 52:2002;503-528.
41. Nobrega J.N., Raymond R., DiStefano L., Burnham W.M. Long-term changes in regional brain cytochrome oxidase activity induced by electroconvulsive treatment in rats. Brain Res. 605:1993;1-8.
42. 125I-iodopindolol to beta-1 adrenoceptors in the amygdala of rat after antidepressant treatments. J Pharmacol Exp Ther. 257:1991;681-690.
43. Payne J.L., Quiroz J.A., Zarate C.A., Manji H.K. Timing is everything Does the robust upregulation of noradrenergically regulated plasticity genes underlie the rapid antidepressant effect of sleep deprivation? Biol Psychiatry. 52:2002;921-926.
44. Pennington R.J. Biochemistry of dystrophic muscle. Biochem J. 80:1960;649-654.
45. Pinna G., Brödel O., Visser T., Jeitner A., Grau H., Eravci M., et al. Concentrations of seven iodothyronine metabolites in brain regions and the liver of the adult rat. Endocrinology. 143:2002;1789-1800.
46. Pinna G., Meinhold H., Hiedra L., Thoma R., Hoell T., Gräf K.J., et al. Elevated 3,5-diiodothyronine concentrations in the sera of patients with nonthyroidal illness and brain tumors. J Clin Endocr Metab. 82:1997;1535-1542.
47. Prange A.J. Novel uses of thyroid hormones in patients with affective disorders. Thyroid. 6:1996;537-543.
48. Risinger C., Bennett M.K. Differential phosphorylation of syntaxin and synaptosome-associated protein of 25 kDa (SNAP-25) isoforms. J Neurochem. 72:1999;614-624.
49. Schmitt AE, Asan B, Püschel, Kugler P (1997): Cellular and regional distribution of the glutamate transporter GLAST in the CNS of rats: Nonradioactive in situ hybridization and comparative immunocytochemistry. J Neurosci 17:1-10.
50. Sheline Y.I., Gado M.H., Price J.L. Amygdala core nuclei volumes are decreased in recurrent major depression. Neuroreport. 9:1998;2023-2028.
51. Sottocasa G.L., Kuylenstierna B., Ernster L., Bergstrand A. An electron-transport-system associated with the outer membrane of liver mitochondria. J Cell Biol. 32:1967;415-438.
52. Thome J., Sakai N., Shin K.H., Steffen C., Zhang Y.J., Impey S., et al. CAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci. 20:2000;4030-4036.
53. Whittaker V.P. The application of subcellular fractionation techniques to the study of brain function. Prog Biophys Mol Biol. 15:1965;41-96.
54. Whybrow P.C., Bauer M. Behavioral and psychiatric aspects of hypothyroidism. Braverman L.E., Utiger R.D. Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text. 8th ed:2000;837-842 Lippincott, Philadelphia.
55. Williams R.S.B., Cheng L., Mudge A.W., Harwood A.J. A common mechanism of action for three mood-stabilizing drugs. Nature. 417:2002;292-295.
56. Wrutniak-Cabello C., Casas F., Cabello G. Thyroid hormone action in mitochondria. J Mol Endocrinol. 26:2001;67-77.